|
Briko N.I., Saltykova T.S., Gerasimov A.N., Suranova T.G., Pozdnyakov A.A., Zhigarlovsky B.A.
Clinical and epidemiological characteristics of influenza in 2015–2016 and 2016–2017
|
№4 / 2017
|
|
Selkova E.P., Aleshkin V.A., Grenkova T.A., Katlinsky A.V., Polezhaeva N.A., Suranova T.G., Lapickaya A.S.
The results of influenza immunoprophylaxis in the 2015–2016 epidemic season
|
№1 / 2017
|
|
Kupchenko A.N., Ponezheva Z.B., Romeyko V.B.
Clinical efficacy of standard antiviral drugs in the treatment of ARVI patients with complications
|
№6 / 2016
|
|
Selkova E.P., Grenkova T.A., Aleshkin V.А., Gudova N.V., . Lytkina I.N., Mikhailova E.V., Yashina A.Ya., Fedyakina I.T.
Investigation of the immunogenicity, efficacy, and tolerability of the Russian vaccine Ultrix® among people at high risk for the infection and morbidity of influenza and acute respiratory viral infections
|
№1 / 2016
|
|
Saltykova T.S., Romanenko V.V., Minaeva O.V.
Epidemiological and economic efficiencies of immunization with the commercial influenza vaccine Grippol® plus in the able-bodied adult population
|
№5 / 2015
|
|
Selkova E.P., Grenkova T.A., Gudova N.V., Oganesyan A.S., Polezhaeva N.A.
Epidemiological importance of influenza vaccination. Russian new-generation influenza vaccine
|
№4 / 2014
|
|
Eganyan G.A., Arutyunyan S.K., Grigoryan S.S., Khizanyan N.S., Sukiasyan S.M., Gevorgyan Zh.K., Maksudyan N.A., Gasparyan A.Z., Donbayan D.A., Ambartsumyan K.G., Papoyan Zh.R., Karakhanyan A.S., Karapenyan M.G., Kazaryan E.R.
Cagocel® treatment of influenza and other respiratory viral infections
|
№4 / 2013
|
|
Briko N.I.
Vaccination is a decisive measure to reduce the burden associated with infectious diseases among adults
|
№4 / 2013
|
|
Dondurey E.A., Osidak L.V., Golovacheva E.G., Suchovetskaya V.F.
Influenza with gastrointestinal symptoms: Causes of development, principles of therapy
|
№2 / 2013
|
|
Romanenko V.V., Ankudinova A.V., Averyanov O.Yu., Chebykina T.V., Spesivtseva L.Yu.
Results of a clinical trial of the safety and efficacy profile of the trivalent inactivated polymer-subunit influenza vaccine Grippol® plus for infants aged 6 months to 3 years
|
№5 / 2012
|
|
Osidak L.V., Zarubayev V.V., Dondurey E.A., Golovacheva E.G., Sukhovetskaya V.F., Drinevsky V.P., Kashayeva O.V.
The natural immunomodular sodium deoxyribonucleate as a drug to treat influenza and acute respiratory viral infection in children (results of preclinical and clinical trials)
|
№1 / 2012
|
|
Nagoyev B.S., Betsukova A.M.
Change in the activity of the antioxidant system in patients with influenza
|
№1 / 2012
|
Русский
